Previous Close | 7.20 |
Open | 7.25 |
Bid | 6.73 x 100 |
Ask | 6.79 x 200 |
Day's Range | 6.70 - 7.25 |
52 Week Range | 3.81 - 17.70 |
Volume | |
Avg. Volume | 260,735 |
Market Cap | 396.81M |
Beta (5Y Monthly) | 0.25 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Over the last year, a good number of insiders have significantly increased their holdings in IGM Biosciences, Inc...
IGM Biosciences ( NASDAQ:IGMS ) Full Year 2023 Results Key Financial Results Net loss: US$246.4m (loss widened by 11...
IGM Biosciences, Inc. (IGMS) delivered earnings and revenue surprises of 4.72% and 31.47%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?